FDA Inspection 1235564 — Ajanta Pharma Ltd.
The FDA completed an inspection of Ajanta Pharma Ltd. on March 5, 2024 in Paithan. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 5, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Paithan (India)